Everyday Health on MSN
C3G/IC-MPGN progression: Can new C3 inhibitors stop the path to dialysis?
For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...
Everyday Health on MSN
C3G/IC-MPGN and hypertension: Treatment and management strategies
Hypertension is both a symptom and complication of kidney disease. With C3G and IC-MPGN, blood pressure management is a foundational ‘shield’ that protects kidney function regardless of other ...
Apellis Pharmaceuticals (NASDAQ:APLS) executives outlined a three-part strategy for the company at TD Cowen’s 46th Annual ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Bethenny Frankel revealed that her chronic kidney disease diagnosis has moved into the next stage. “Just left the kidney doctor, he said I actually have stage 3A chronic kidney disease which is right ...
Assessing Apellis Pharmaceuticals (APLS) Valuation After Weaker Returns And EMPAVELI Label Expansion
Recent share performance and business snapshot Apellis Pharmaceuticals (APLS) has drawn fresh attention after a stretch of weaker share performance. The stock is around $18.94 and has recorded ...
Nearly a month after the Real Housewives of New York City alum announced she was diagnosed with stage 2 chronic kidney disease, she revealed her condition has progressed to stage 3A. “I just left the ...
Kidney stones are made of crystallized salts and minerals. Severe kidney stone pain and blood in your urine require medical attention. Drinking water and taking pain relievers can help you manage ...
The Kidney, Urology, and Non-Malignant Hematology (KUH) Undergraduate Research Experience program is a 12-week (8 weeks on campus), NIH-funded Summer Research Program. This program focuses on ...
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results